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ABSTRACT 
 
Placenta-specific 1 (Plac1) is an X-linked gene that is essential for normal placental 
development. Previous studies have shown that Plac1 is also expressed in the fetal brain and 
paternally imprinted. Its expression in the fetal brain is markedly downregulated immediately 
after birth. Plac1 ablation predisposes Plac1-null males and Xm-X Hets (inactive maternal allele) 
to an increased risk of developing lethal postnatal hydrocephalus suggesting a functional role for 
Plac1 during embryonic development. The objective of this study was to characterize the effect 
of Plac1 on brain development and postnatal function. In order to address this, a mutant Plac1 
mouse model, established on the C57BL/6J background, was studied. Formalin-fixed, paraffin-
embedded whole mount embryos and brain sections were obtained at various stages of 
development. Plac1 expression was assessed by qRT-PCR and immunohistochemistry (IHC). 
Brain structure was assessed by histopathological and magnetic resonance imaging (MRI) 
analysis. Behavioral analysis was conducted using the PhenoMaster automated cage system and 
a battery of classical behavioral tests. Our results revealed Plac1 expression throughout the 
embryonic brain when assessed by qRT-PCR and IHC at E16.5 and E18.5. MRI analysis of an 
adult Plac1 knockout (KO) brain revealed microcephaly (14%), reduced ventricular volume, and 
increased heterogeneity of the medulla compared to a WT brain. Consistent with these findings, 
H&E staining of the KO brain revealed a smaller cortical mantle, a dysmorphic hippocampus, 
and a dysmorphic cerebellum with reduced folia. IHC analyses of NF-M, NeuN, and Iba1 
immunostaining revealed significant reductions in axonal and neuronal development and 
vi 
 
increased activated microglia in KO brain, but not in Xm-X Hets. Although no structural 
abnormalities were detected in Xm-X Hets, behavioral analyses did reveal reduced activity and 
behaviors consistent with increased anxiety. In conclusion, Plac1 is a paternally imprinted, X-
linked gene that is associated with abnormal brain development, reduced activity, and specific 
behavioral abnormalities. 
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CHAPTER ONE: 
 
INTRODUCTION 
 
The PLAC1/Plac1 Gene 
Placenta-specific 1 (PLAC1) is an X-linked gene that was originally believed to be 
expressed solely in the placenta. Northern blot analysis and in situ hybridization at the time 
suggested PLAC1 expression was restricted to placental trophoblasts during development 
(Cocchia et al., 2000; Fant et al., 2002). Expression of murine Plac1 is highest in the placenta 
from embryonic days 7.5-14.5 (E7.5-E14.5). Expression was reported to be restricted to 
trophoblast-derived cells, including cells in the spongiotrophoblast, placental labyrinth, and 
trophoblast giant cells. In humans, PLAC1 expression remains relatively constant from 22 to 40 
weeks of development (Fant et al., 2002; Massabbal et al., 2005). Recent research has elucidated 
a more complicated expression profile where its expression was shown to occur throughout the 
entire embryo, in particular, the brain, heart, kidney, and lungs (Jackman, Kong, & Fant, 2012; 
Kong, Jackman, & Fant, 2013). Interestingly, expression has also been detected in a wide range 
of tumors and transformed cell lines (J. Chen et al., 2006; Koslowski et al., 2007; Silva et al., 
2007). Placental tumor choriocarcinoma cell lines BeWo, JAR, and JEG, neuroblastoma cell line 
LA1-56, and a number of others had significant PLAC1 expression. PLAC1 was also expressed 
in approximately 82% of primary breast tumors and 50% of gastric tumors. 
PLAC1 maps to Xq26, 65 kilobases telomeric to the gene hypoxanthine-guanine 
phosphoribosyltransferase, which codes a protein important in purine metabolism (Cocchia et al., 
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2000). This area of the X chromosome is considered important for fetal development. Large 
deletions (200-700 kb) around the Hprt locus in several mice resulted in a runty phenotype or 
death (Kushi et al., 1998). Also, this region has been implicated in interspecific hybrid viability 
(Zechner et al., 1996). The deletion of the Hprt gene itself does not result in abnormal placental 
phenotype in mice, suggesting that some gene(s) nearby, such as PLAC1, may be responsible 
(Searle, Edwards, & Hall, 1994). 
PLAC1 has six exons, with the last exon coding for the protein (Y. Chen, Moradin, 
Schlessinger, & Nagaraja, 2011). PLAC1 contains two active promoters, P1 and P2. P1 lies 
upstream of the first exon, while P2 lies just upstream of exon 4.  This unique structure is 
conserved in mouse Plac1. Nuclear receptors retinoid X receptor alpha (RXRα) and liver X 
receptor (LXR) activate both promoters, and putative RXRα binding sites have been detected on 
P1. Both receptors are expressed prominently in the placenta during development. RXRα is the 
dominant isoform in placenta, and selective knockout is associated with several severe placental 
defects and potential embryolethality (Sapin, Dolle, Hindelang, Kastner, & Chambon, 1997). In 
normal placenta, P2 is the primary promoter. However, in studied cancerous cell lines, the 
preferred promoter is variable (Y. Chen et al., 2011). The significance of the different PLAC1 
isoforms is unknown. 
 
The PLAC1/Plac1 Protein 
 The putative PLAC1 protein is relatively small. The human open reading frame (ORF) 
encodes a protein of 212 amino acids; the mouse Plac1 protein is 173 amino acids but very 
homologous to human – 75% similar at the DNA level and 60% at the amino acid level (Cocchia 
et al., 2000). The amino acid sequence contains a signal peptide, suggesting that PLAC1 is likely 
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targeted to the secretory pathway and exists as an extracellular protein. Interestingly, both 
proteins share sequence homology with zona pellucida 3 protein, a specific sperm-binding 
protein in the zona pellucida critical for fertilization. This zona pellucida domain (ZPD) has been 
found and characterized in other secreted glycoproteins, such as uromodulin and betaglycan 
(Bork & Sander, 1992; Jovine, Qi, Williams, Litscher, & Wassarman, 2002). In particular, this 
domain is used for cross-linking and polymerization along the sequence, suggesting that PLAC1 
may also possess such an attribute. The presence of the ZPD, alongside immunohistochemical 
localization studies, suggest that PLAC1 is a secreted or membrane-bound protein. Furthermore, 
the lack of cytoplasmic signaling domains in PLAC1 suggests that the protein likely modulates 
signaling transduction pathways mediated by other receptors (Fant, Farina, Nagaraja, & 
Schlessinger, 2010). 
PLAC1 also appears to elicit an antibody response. Some patients with high-PLAC1 
expressing cancers were found to have developed circulating anti-PLAC1 antibodies. In a study 
of patients with colorectal cancer, approximately 50% of tumor samples expressed detectable 
PLAC1 mRNA (Liu et al., 2008). Of patients with these tumors, more than half expressed 
responsive T cells, and about 30% expressed spontaneous auto-antibodies against PLAC1. In a 
study of patients with hepatocellular cancer, 32% of samples expressed PLAC1, and 4% of all 
patients were seropositive for PLAC1 antibodies (Dong et al., 2008). Preliminary analysis of the 
patients of both studies suggested that the presence of these PLAC1 auto-antibodies provided a 
significant survival advantage. These data suggest not only that PLAC1 has some distinctive role 
in cancer biology, but also that targeting the PLAC1 antigen may be a viable therapeutic 
strategy. Indeed, PLAC1 silencing and PLAC1 neutralization by antibodies in MCF-7 breast 
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cancer cells resulted in decreased motility, invasiveness, and cell proliferation (Koslowski et al., 
2007). 
 
PLAC1 Function 
 The mechanism of action for PLAC1 is unknown. The prior discussion on the putative 
sequence of the PLAC1 protein and experiments exploring the relationship of PLAC1 in various 
cancers suggests that the protein plays some role in migration and invasion of placental 
processes. The interactive ZPD and lack of cytoplasmic signaling domains suggests modulation 
of other signaling protein pathways. Differential microarray analysis of E18.5 KO placentae 
revealed downregulation of several genes important in embryogenesis, including Bmp, Wnt, and 
Pdgf (Fant, unpublished data). Canonical pathways implicated include “ES Cell Pluripotency”, 
“Integrin Signaling”, “Glioblastoma Multiform Signaling”, and “Axonal Guidance Signaling”. 
PLAC1 is required for normal placental development. Intensive study of a mutant mouse 
model in our laboratory demonstrated that ablation of Plac1 resulted in significant 
placentomegaly (100% increase) and intrauterine growth retardation (IUGR) (Jackman et al., 
2012). The effect was most pronounced in male Plac1 knockouts (KOs), followed by Xm-X Hets 
(inactive maternal allele). No female KOs were identified postnatally. While examining the 
postnatal phenotype of mutant Plac1 mice, a number of interesting and important observations 
were made. First, KO males exhibited decreased postnatal viability. Approximately 20-25% of 
the expected number of KO males survived. Second, and more surprisingly, although some 
surviving KO males appeared normal and were fertile, 22% developed lethal hydrocephalus 
(HC) at 4-8 weeks of life (Kong et al., 2013). Third, although the Xm-X heterozygotes exhibited 
normal postnatal viability they also exhibited an increased risk (11%) of developing lethal 
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hydrocephalus at 4-8 weeks of age. These observations strongly suggested a functional role for 
brain-derived Plac1 in brain development and function. 
 In the work described in this thesis, we further examined Plac1 expression in the brain 
during development. We show that Plac1 KO mice exhibit a number of histological 
abnormalities and structural malformations. Furthermore, we report that female Plac1 Hets (Xm-
X) exhibit reduced activity likely related to anxiety using both automated cage observation and 
specific behavioral testing. 
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CHAPTER TWO: 
 
METHODS 
 
Plac1 Mutant Mouse Model 
Mutant mice were bred against a C57/BL6 background as described previously (Jackman 
et al., 2012). The Plac1 open reading frame on exon 6 was deleted in murine embryonic stem 
(ES) cells by the Knockout Mouse Project (KOMP) VelociGene approach (KOMP-NIH 
initiative; http://www.velocigene.com/komp/detail/10766). Blastocysts were injected with Plac1-
null ES cells to produce chimeras (KOMP). Mice were bred against C57BL/6 background once 
germline transmission was established. Procedures and protocols such as timed mice matings 
were carried out in accordance with Institutional Animal Care and Use Committee (IACUC) of 
the University of South Florida College of Medicine Protocol Number R4228 (Appendix A). 
 
Genotyping Determination for Mice 
Genotyping was performed using PCR as described elsewhere (Kong et al., 2013). DNA 
was isolated from embryonic mouse tails using a DNeasy Blood and Tissue Kit (Qiagen, 
Valencia, CA). Plac1 genotype was determined by PCR, using the following primers: 50-
CCAATCATGTTCACCCACATTTCTAC (WT forward);  
50-CCCTAAAAGAGCTATCATGGCATCT (reverse);  
50-GCAGCCTCTGTTCCACATACACTTCA (neomycin universal forward). The cycling 
parameters were: 94°C for 5 min, followed by 10 cycles of 94°C for 15 sec, 65°C for 30 sec 
7 
 
(decreased by 1°C at each repeat), and 72°C for 40 sec; followed by 30 cycles of 94°C for 15 
sec, 55°C for 30 sec, and 72°C for 40 sec. PCR products were terminated with a final extension 
at 72°C for 5 min, then held at 4°C. A 1% agarose gel was used to visualize the generated 
wildtype and mutant bands at 548 and 326 bp, respectively. 
 
Quantitative Measurement of Brain Plac1 mRNA 
WT pregnant females were euthanized at E16.5 and E18.5 during gestation and the brains 
collected. Specific regions of each embryo’s brain were dissected under a dissecting microscope, 
placed in RNAlater (Qiagen, Valencia, CA), and pooled with the same region collected from the 
other littermates. Total RNA was then prepared using the AllPrep DNA/RNA Kit (Qiagen). 
Plac1 mRNA was measured by qRT-PCR and normalized against 18S ribosomal RNA as 
described in Kong et al. 2013 (Kong et al., 2013). The brain regions (cerebellum, medulla, pons, 
etc.) pooled from embryos derived from one litter constituted 1 sample. The average expression 
for each region was determined from at least 2 litters.  
 
Hemotoxylin and Eosin (H&E) Staining 
 H&E staining was performed by the Moffitt Tissue Core (http://moffitt.org/research--
clinical-trials/research-cores--technology/tissue-core) using a standard protocol. 
 
MRI Analysis 
 Mice underwent a T2-weighted MRI. Regions of interest, in particular the ventricles, 
medulla, and hippocampus, were drawn and compared using the Aedes software package 
(Aedes, Finland, http://aedes.uef.fi/). 
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Immunohistochemistry 
Paraffin embedded tissue were cut into 5 uM sections onto glass slides. The slides were 
deparaffinized in xylene (Thermo Fisher Scientific, Waltham, MA) for 2x10 min, rehydrated in 
100% EtOH for 2x5 min, 95% EtOH for 5 min, 75% EtOH for 5 min, 50% EtOH for 5 min, and 
finally in dH2O for 5 min. The slides were washed in Phosphate buffered saline (PBS) for 10 
min. and excess liquid drained. The slides were washed with PBT (PBS + 0.1% Tween-20) for 
3x5 min, and then incubated in blocking buffer (10% serum of secondary antibody host serum in 
PBT) for 1 hour at room temperature. The slides were then incubated in primary antibody in 
blocking buffer overnight at 4°C. Non-specific staining was determined by incubating with 
homologous non-immune serum (dilution equivalent to primary antibody). The slides were then 
washed in PBT 3x5 min. and incubated with IgG from primary antibody host (VectaStain Elite 
ABC kit, Vector Labs, Burlingham, CA) for 1 hour. The slides were placed in ABC reagent (per 
protocol) for 30 min and washed in PBT 3x5min, stained using diaminobenzidine substrate, then 
mounted. Primary antibodies and dilutions used include anti-Plac1 (Abbomax, San Jose, CA, 
1:200 dilution), anti-NF-M (Santa Cruz Biotechnology, Dallas, TX, 1:50 dilution), anti-NeuN 
(Millipore, Billerica, MA, 1:125 dilution), and anti-Iba1 (Wako Pure Chemical Industries, 
Osaka, Japan, 1:333 dilution). 
 
Image Analysis 
Immunohistochemical pictures were quantitatively analyzed using ImageJ v1.46r 
software (NIH, http://imagej.nih.gov/ij/download.html). Color threshold RGB values were 
obtained manually, then applied systematically to each sample using built-in function “Analyze 
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Particles” to obtain area percent stain or number of cell bodies. Parameters were chosen 
appropriately to accurately capture cell bodies or positive staining regions. 
 
PhenoMaster Analysis 
The PhenoMaster system (TSE Systems GmbH, Bad Homburg, Germany) is a modular 
automated high-throughput home-cage environment capable of recording physiological and 
behavioral data with high spatial and temporal resolution (Clemens, Jansson, Portal, Riess, & 
Nguyen, 2014; Urbach et al., 2014). The setup used for these studies allowed simultaneous 
observation of 12 mice. The experimental window consisted of 5 days. The 5 day observation 
period was split into two time frames – the first 24 hours of monitoring, or “Day 1”, and the 
remaining 96 hours, or “After Day 1”. This was done to separate the acclimation or exploration 
period from the period of normal activity. There was further stratification by light, dark, and both 
cycles. Raw data was compressed within the PhenoMaster software. Data was extracted and 
analyzed using Microsoft Excel. 
 
Specific Behavioral Testing 
Mice were also subjected to a battery of well-described rodent behavioral tests, including 
the Elevated Plus Maze (EPM), Open Field Test (OF), Y-maze, Novel Object Recognition Test 
(NOR), Rotarod, and Radial Arm Water Maze (RAWM). 
 
Elevated Plus Maze  
The EPM was employed to evaluate anxiety as described elsewhere (Arendash et al., 
2001). The maze consisted of four arms (30 x 5cm) connected by a central area (5 x 5cm), all 
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constructed of plywood and painted black. Two opposite-facing arms were open, while the other 
two were enclosed by aluminum sheet walls 15 cm high. The maze was elevated 82 cm above 
floor level. One mice at a time was placed in the central area, and its movement was recorded by 
ceiling video camera during a single 5 minute trial. The data was analyzed using video tracking 
software ANY-maze (ANY-maze, Stoelting, IL). Between mice, the maze was cleaned using 
70% ethanol to minimize olfactory cues. 
 
Open Field Test 
Animals were monitored for 15 minutes in a 40 cm square open field with video tracking 
software (ANY-maze, Stoelting, IL), under moderate lighting as a standard test of general 
activity. 
 
Y-maze 
Each animal was placed in a walled Y-maze and allowed to roam freely for a single 5 
minute trial. The sequence of arm entries and total number of arm choices were recorded. 
Spontaneous alternation, or the proportion of arm selections made consecutively without 
repetition, was calculated and expressed as a percentage (Anisman, 1975). 
 
Novel Object Recognition Test 
Described elsewhere (Brownlow et al., 2014). The test consists of a 40 x 40 cm area 
monitored by video tracking (ANY-maze, Stoelting, IL). Two objects similar in scale to the 
mouse were placed along the center line of the arena approximately 3-5 cm from the outside 
wall. Each animal was given three acclimation trials of 5 minutes each with 5 minutes in 
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between. After each trial, the arena and object cues were cleaned with 70% ethanol to minimize 
olfactory cues. Five minutes after the final acclimation trial, one of the objects was replaced by a 
novel object. The mice were then observed by video tracking over a 5 minute exploratory trial. 
Working memory was assessed by the exploration index, defined as the time spent exploring the 
novel object over total exploration time. 
 
Rotarod 
Described elsewhere (Morgan et al., 2008). Mice were placed onto the round portion of a 
motorized circular rod (Ugo Basile Rota-rod model 7750). Mice were required to walk at the 
speed of rod rotation to prevent falling. The rod slowly accelerated every 30 seconds from 2.5 
RPM to 34 RPM over 5 minutes. Time until falling was recorded for each mouse. Mice were 
given three trials each day, separated by at least ten minutes, for 5 consecutive days. The average 
time until falling for each day was recorded. The maximum possible time on the rod is 300 
seconds, which is rarely met. 
 
Radial Arm Water Maze 
The test contained six swim arms radiating from an open central area, with a submerged 
hidden escape platform located at the end of one of the arms. Starting with a randomly selected 
arm, the mice were placed at the end of an arm and was allowed to swim in the maze for up to 60 
seconds to find the escape platform. The escape platform was located in the same arm each trial. 
On day one, mice were given 15 trials (three per block) alternating between a visible platform 
(above the water) and a hidden one (below the water). The following day, they were given 15 
trials with every trial using a hidden platform. The start arm was varied for each trial to 
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emphasize mice learning by spatial cues rather than motor learning. Entry of all four limbs in an 
incorrect arm or failure to enter the correct arm within 20 seconds was scored as an error. Errors 
for the three trial blocks were averaged for data analysis. On the third day, a reversal experiment 
was performed with the goal placed in the arm opposite (180°) from the original location. Mice 
were given 15 trials to unlearn the first location and find the second location through training. On 
the fourth day, the arms were removed, the platform was raised above the water, and a flag was 
attached to the platform to confirm all mice were capable of seeing and climbing onto the 
platform (open pool). The time taken to reach the platform was recorded. 
 
Statistical Analysis 
Data obtained from ImageJ stain analyses were compared using Student’s T test. 
Variables obtained from PhenoMaster analysis were stratified by age, experimental phase, and 
day status (ie. light, dark), and compared using Student’s T-test. Variables recorded from the 
remaining specific behavioral tests were compared using Student’s T-test. Comparison of 
variables along time were analyzed using repeated measures ANOVA. An alpha of 0.05 was 
applied for all tests performed. 
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CHAPTER THREE: 
RESULTS 
 
PLAC1 is Expressed Throughout the Fetal Brain 
In order to establish the pattern of Plac1 expression during fetal development, Plac1 
mRNA was measured in various regions of the brain using quantitative real-time PCR (qRT-
PCR). Brains were obtained from WT embryos at E16.5 and E18.5 (n = 2 litters) and divided 
into distinct anatomical regions. Total RNA was subsequently obtained and quantified. Plac1 
mRNA was detected throughout the fetal brain especially the pons, midbrain, cerebellum, and 
hippocampus (Figure 1). These findings are consistent with previously reported data from our 
laboratory that localized Plac1 mRNA to the periventricular cortex, pons/medulla, and 
cerebellum by in situ hybridization (Kong et al., 2013). 
 
 
Figure 1. Plac1 mRNA expression by anatomy in the mice brain at E16.5 and E18.5. n = 2 each. 
Plac1 mRNA was obtained from respective areas of mice brain at appropriate developmental 
stage. Individual samples were done in triplicate. 
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Localization of Plac1 expression during development was further explored using 
immunohistochemistry (IHC). Anti-Plac1 polyclonal antibodies were used to perform DAB-
brown immunostaining on whole-mount WT, Xm-X Hets, and KO embryos at E18.5 according to 
protocol (Figure 2). In the WT embryo, Plac1 was detected throughout the brain, particularly in 
the vomeronasal organ, the olfactory bulb, and the cerebral cortex. Plac1 expression in the Het 
and KO were appreciably lower, verifying the specificity of the anti-Plac1 antibody used. These 
findings are consistent with the qRT-PCR data, suggesting that Plac1 may have a general role in 
brain development. 
 
 
Figure 2. Plac1 localization by Immunohistochemistry using anti-Plac1 antibody of E18.5 
whole-mount embryos. OB – olfactory bulb, VM – vomeronasal organ, C – cerebral cortex. 
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Ablation of Plac1 Results in Abnormal Brain Structure 
In order to gain insight into possible neurological functions for Plac1 during brain 
development, brains of postnatal mice of each genotype were obtained and compared using a 
variety of relevant criteria. H&E staining of WT and KO mice revealed a number of striking 
histological changes, including decreased size of lateral ventricles, disorganized neuronal 
distribution, especially on the parietal cortex, and a simpler cerebellum with reduced folia 
(Figure 3). These findings are consistent with prior MRI analysis of WT and KO brains, which 
showed KO brains have 12% decreased overall brain volume and 14% decrease in ventricular 
volume, adjusted for total brain volume (Figure 4). Furthermore, MRI revealed greater tissue 
heterogeneity in the KO medulla compared to WT, indicating possible structural abnormalities in 
the observed brain (See Tables 1 and 2). 
 
 
Figure 3. H&E stain comparison of KO and WT mice brains. Significant alterations include 
narrowed ventricles (A vs. D), abnormal cell organization with disorganized parietal cortex 
layering (B vs. E), and truncated cerebellar folia (C vs. F). 
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Figure 4. MRI visualization of KO and WT brains. KO brain (left, red) is visibly smaller than 
WT brain (right, green). MRI image analysis results displayed in Tables 1 and 2. 
 
Region of Interest Relative Volume 
Relative Normalized 
Volume 
Lateral Ventricles 0.8340898 0.962676 
Third Ventricle 0.5471264 0.631473 
Fourth Ventricle 0.4681529 0.540325 
Total Ventricular Volume 0.7463397 0.861398 
Brain 0.8664287 1 
Table 1. MRI volumetric comparison of KO and WT brains. The KO brain is approximately 
14% smaller than WT control. Furthermore, ventricular volume normalized to total brain smaller 
is 14% smaller in KO than WT control. 
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Region of Interest 
Relative Mean CSF 
Intensity 
Relative St. Dev Difference? 
Lateral Ventricles 1 0.9889617 Very similar 
Third Ventricle 0.91061255 0.91115869 similar 
Fourth Ventricle 0.94020847 0.98043895 Very similar 
Cerebellum 0.98558179 0.9490877 similar 
Medulla 0.99962243 1.38080484 Different STD 
Hippocampus 0.92353926 0.93530759 Very similar 
Brain 0.92366099 0.98755128 Very similar 
Table 2. MRI voxel intensity comparison of KO and WT brains. The standard deviation of voxel 
intensity in the medulla is approximately 38% greater in the KO than WT control, indicating 
significant tissue heterogeneity. 
 
A Plac1 KO Mouse Exhibited Altered Expression of NeuN, NF-M, and Iba1, While Xm-X 
Hets Appeared Unaffected 
In order to characterize specific neurological disturbances Plac1 ablation may instigate 
later in life, mouse brains of each genotype were obtained and compared using 
immunohistochemistry of various markers. Specifically, anti-Neuronal Nuclei (NeuN) and anti-
Neurofilament-M (NF-M) were employed to assess potential neuronal and axonal damage. A KO 
male brain exhibited significantly less NF-M expression than a male WT control, particularly in 
the corpus callosum and caudate putamen (Figure 5). Analysis of anti-NeuN staining revealed 
decreased staining and neuronal cell count in the cerebellum, hippocampus, and cortex (Figure 
6). These data revealed that ablation of Plac1 expression resulted in decreased expression of 
NeuN and NF-M, and interfered with normal axonal guidance. 
Furthermore, immunohistochemical staining against Iba1, a marker for activated 
microglia, allowed assessment of potential inflammatory consequences of Plac1 ablation in the 
postnatal nervous system. Anti-Iba1 staining revealed significantly more activated microglia 
throughout the brain in KO and Hets compared to WT equivalent later in life (Figure 7).  
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Figure 5. Comparison of NF-M expression between male WT (WT-M) and male Plac1 KO 
mice. KO mice brain show reduced NF-M expression and decreased axonal migration. NF-M 
reduction in the KO brain compared to WT-M is evident throughout the entire brain, especially 
in the corpus callosum, caudate putamen, and pons-medulla (A-C). Axonal migration in the 
caudate putamen is visually hindered in the KO brain (D-F). 
 
 
Figure 6. Comparison of NeuN expression between male WT (WT-M) and male Plac1 KO mice. 
WT-M neuronal expression in the cortex, cerebellum, and hippocampus (A-C) visually 
outweighs expression in the KO equivalent (D-F). 
A B C 
D E F 
WT-M KO N.C. 
WT-M 
KO  
Cortex Cerebellum Hippocampus 
F E D 
C B A 
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Figure 7. Iba1 IHC comparison between male WT (WT-M) and male Plac1 KO mice. KO mice 
brain show significantly more activated microglia than WT. Pattern exists throughout the brain, 
but particularly in the cortex. 
 
Chronically activated microglia are usually suggestive of neuronal damage and 
neurodegenerative disorders (Dheen, Kaur, & Ling, 2007). Plac1 ablation thus may predispose 
mice to increased neuronal loss later in life. 
Interestingly, NeuN, NF-M, and Iba1 expression of Xm-X Hets seem largely unchanged 
compared to female age-matched WT mice. At 11 months, there is no appreciable difference 
between stains for any marker (Figure 8). This similarity is confirmed using quantitative analysis 
done through ImageJ. It appears that the paternal allele has enough function to rescue Xm-X Hets 
from histological neuronal and axonal abnormalities throughout adulthood. 
 
Reduction of Plac1 Expression Affects Various Behavioral Parameters in Mice 
In order to detect potential downstream behavioral and phenotypical changes associated 
with reduction Plac1 during development, female WT (WT-F) and Xm-X Hets (HETs) at various 
matched ages were analyzed in both automated cage environments and classical test apparatuses. 
Mice were first continuously monitored using the TSE PhenoMaster system. 
 
WT-M KO 
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Figure 8. Comparison of staining of female WT (WT-F) and Plac1 Xm-X heterozygotes (HET) at 
11 months. WT-F and HETs stain similarly using NF-M (A vs. B). NeuN is similar at the 
cerebellum (C vs. D), cortex (E vs. F), and hippocampus (G vs. H). Iba1 is similar throughout 
the brain (I vs. J). Quantitative threshold analysis using ImageJ (n = 3 each) confirms visual 
similarities (K-M). 
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PhenoMaster 
PhenoMaster analysis revealed a number of significant differences in activity and 
mobility parameters between WT-F and HETs (Figure 9). During Day 1, HETs at 5 months (nWT-
F = 4, nHET = 4) exhibit decreased fine beam breaks (p = 0.006), increased locomotive speed (p = 
0.038), and increased time asleep in the dark phase (p = 0.014), and decreased time active 
considering both phases (p = 0.049). Over the entire experimental period, HETs at 5 months 
show noticeably increased rearing activity (p = 0.049). HETs at 12 months (nWT-F = 7, nHET = 4) 
spend significantly more time in the periphery of the cage rather than the center in the light phase 
of both Day 1 (p = 0.037) and After Day 1 (p = 0.039), and increased rearing during the dark 
phase after Day 1 (p = 0.050). Interestingly, when observing the sleeping habits of HETs at 5 
months, these mice slept much more during the Day 1 than After Day 1, when the opposite is 
expected. There were no significant alterations in feed and drink habits, or metabolic parameters 
along either experimental period or age group. Collectively, these findings show that reduced 
Plac1 expression during development is associated chiefly with decreased overall activity during 
the acclimation phase at 5 months, and increased exploration and rearings throughout the entire 
experiment at 12 months. 
 
Specific Behavioral Testing 
WT-F and HETs were further analyzed using a variety of classical behavioral tests. In 
order to assess mobility and behaviors associated with anxiety, the Elevated Plus Maze (EPM) 
and Open Field (OF) test were employed. The Y-maze was used to assess spatial working 
memory. The Novel Object Recognition (NOR) test provided a measure of cognition and 
recognition memory. Motor coordination, balance, and motor learning were assessed using the  
22 
 
 
 
 
 
Figure 9. PhenoMaster analysis and comparison of female WT (WT-F) and Plac1 Xm-X 
heterozygotes (HET) at 5 months (n = 4 each) and 12 months (nWT-F = 7, nHET = 4). At 12 
months, WT-F mice at 12 months spend significantly more time in the center in both the 
acclimation phase (A) and during the Light phase in After Day 1 (B). HETs at 5 months are 
asleep more often in the Dark phase of Day 1 (C) and display an abnormal sleep acclimation 
between experimental phases (D). Rearing were more common in HETs at 5 months during the 
Light phase overall (E) and HETs at 12 months during the Dark phase After Day 1 (F). Fine 
movements were significantly reduced in HETs at 5 months during the Dark phase in the 
acclimation phase (G). HETs at 5 months on Day 1 were also less active overall (H) yet faster 
during the active phase (I). Data represents means ± SEM (**p < 0.05, ***p < 0.01) 
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Rotarod. Finally, spatial working memory and spatial learning were compared between the two 
groups using the Radial Arm Water Maze (RAWM). 
The EPM revealed further differences between WT-F (nWT-F = 5) and HET (nHET = 3) 
mice at 16 months (Figure 10). There were no appreciable differences between HETs and WT-F 
mice with regard to most classical anxiety-related parameters, including percent time in open 
arms (p = 0.254), percent time mobile in open arms (p = 0.277), and ratio distance traveled in 
open arms (p = 0.285). However, none of the HETs explored the entirety of the open arms, as 
shown by respective heat maps, and HET mice heads entered the open arm zone less frequently 
(p = 0.034). Furthermore, there were substantial differences between genotypes with regard to 
locomotor skills, including total distance traveled (p = 0.001) and time immobile (p = 0.007). 
 
 
Figure 10. Elevated Plus Maze analysis of female WT (WT-F, 16 mo., nWT-F = 5) and Plac1 X
m-
X heterozygotes (HETs, 16 mo., nHET = 3). HETs traveled significantly less and were much less 
mobile than WT-F, and HET mice heads entered the open arm zone less frequently (A). HETs 
traveled less and spent less time than WT-F in the Open Arms, but were not statistically different 
(B). However, unlike the WT-F, HETs did not explore most of the open arms (C). Heat maps 
represent group occupancy plot of mice center position. Data represents means ± SEM (**p < 
0.05, ***p < 0.01, ****p < 0.005) 
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Further behavioral testing found no additional significant differences between WT-F and 
HETs. OF testing (nWT-F = 7, nHET = 4) found a small but insignificant reduction in total distance 
traveled, both overall (p = 0.279) and by three minute intervals (p = 0.99). HETs were slightly 
more immobile (p = 0.103) and slower (p = 0.284), but were identical in regards to propensity to 
the center (p = 0.941), the chief measurement for anxiety (Figure 11). Y-maze analysis showed 
no differences in arm entries (p = 0.640) or percent alternation (p = 0.191) between WT-F and 
HETs (Figure 12ab). The NOR test (nWT-F = 7, nHET = 3) showed no differences in attention paid 
to the novel object (p = 0.896) and only slight reduction in discrimination ratio (p = 0.627) 
(Figure 12cd). Rotarod analysis (Figure 12e) showed no overt deficiencies between WT-F and 
HETs in continual motor control and learning in day 1 of testing (p = 0.175) nor day 2 (p = 
0.278). The RAWM (nWT-F = 6, nHET = 3) showed a very modest increase in entry errors for 
HETs (p = 0.884). There was no difference in error improvement over time in neither day 1 (p = 
0.860), nor day 2 (p = 0.070). Furthermore, reversal of the maze showed no learning impairment 
over time (p = 0.573), and open pool testing confirmed no visual or motor impairments (Figure 
13). 
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Figure 11. Open field test comparison of 16 mo. female WT mice (WT-F, nWT-F = 7) and 16 mo. 
Plac1 Xm-X heterozygotes (HETs, nHET = 4). Mice are placed into a novel box environment and 
resultant activity is recorded. HETs travel only slightly less than WT-F (A), and are comparable 
over time (B). HETs are slightly less mobile (C) and slightly slower (D) than WT-F, but these 
observations are not statistically significant. HETs and WT-F are similar with regards to time 
spent in the center of the field (E). 
 
 
Figure 12. Y-maze, Novel Object Recognition, and Rotarod performance comparisons of female 
WT mice (WT-F) and Plac1 Xm-X heterozygotes (HETs). Y-maze (nWT-F = 7, nHET = 4) revealed 
no significant differences in total number of entries (A), or percent of entries where the mice 
enters all three arms sequentially without revisiting a previously selected arm (percent 
alternation, B). In Novel Object Recognition (nWT-F = 7, nHET = 3), analysis revealed no 
significant change in percent time exploring the new object vs. the old (C) or ratio of time spent 
attending to the new object over the duration of the test (determination ratio, D). Rotarod (nWT-F 
= 7, nHET = 4) test showed no significant difference between genotypes with regard to time 
before falling off or performance improvement (E). 
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Figure 13. Radial Arm Water Maze (RAWM) test performance comparison of 16 mo. female 
WT mice (WT-F, nWT-F = 6) and 16 mo. Plac1 X
m-X heterozygotes (HETs, nHET = 3). In the 
RAWM, mice are placed into a pool with six arms, with an escape platform at the end of one 
arm. After 15 trials, mice rest for one day. The subsequent day of testing begins with the exit in 
the same location as the final trial of the first day. WT-F and HETs perform similarly with regard 
to learning performance (A) and total errors (B). On the third day, the exit for each trial is 
opposite (180°) of the original location. There was no apparent difference between genotypes 
with regards to adapting to this reversal (C) or total errors during the reversal experiment (D). 
On the fourth day, the arms are removed from the pool, the platform is elevated, and a large flag 
is placed on the goal. Mice are tested in this fashion to ensure that the mice can see and are able 
to climb onto the platform. There were no deficiencies for any mice (E). 
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CHAPTER FOUR: 
DISCUSSION 
 
In this study, we find that Plac1 is expressed throughout the entire fetal brain during 
embryogenesis. Ablation of Plac1 results in histopathological abnormalities, including stunted 
hippocampal, cerebellar, and cortical growth, and reduced volume of the lateral ventricles. 
Furthermore, KOs show reduced neuronal and axonal expression, and an increase in microglial 
activation. Plac1 mutants have been previously shown to be at risk for lethal hydrocephalus 
(HC), with an 11% and 22% increase in risk for Xm-X heterozygotes (HETs) and KOs 
respectively (Kong et al., 2013). L1CAM, a neural adhesion glycoprotein, serves as the genetic 
basis for most cases of X-linked HC (Jouet et al., 1993). L1CAM additionally has the capability 
to interact with FGF receptors, similar glycoproteins such as such as phosphaglycan, and its 
surrounding environment, to induce signaling cascades (Weller & Gartner, 2001). PLAC1 is a 
putative glycoprotein containing a zona pellucida 3 motif (Cocchia et al., 2000), a module 
important in protein-protein interactions and polymerization (Jovine et al., 2002). Although the 
mechanism of PLAC1 action is unknown, we speculate that it may interact with L1CAM-
dependent developmental and regulatory pathways during embryogenesis. 
Knowing that Plac1 ablation is associated with increased risk of fatal postnatal HC, we 
were surprised to observe that the knockout mice studied displayed restricted lateral ventricles 
compared to the WT control. X-linked HC is typically associated with enlargement of the lateral 
ventricles (Dahme et al., 1997; Fransen et al., 1998). There are a couple explanations for this 
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observation. First, there is considerable variability of observed phenotypes in genetic mouse 
models of disease that is dependent on factors such as mouse strain, genetic background, and 
environmental influences (Cohen et al., 1998; Dahme et al., 1997; Doetschman, 2009; Fransen et 
al., 1998; Kenwrick, Jouet, & Donnai, 1996). Second, Plac1 KOs show considerably reduced 
viability (Jackman et al., 2012). The studied KO may display a milder phenotype that allowed 
this individual animal to avoid developing HC. The exact mechanism of how Plac1 influences 
the development of X-linked HC remains to be elucidated. 
We next attempted to determine if Plac1 ablation led to long-term phenotypic changes in 
adult mice. Although there were insufficient numbers of male KOs to study, we speculated that 
female HETs would likely be affected. The PhenoMaster system was used to begin 
characterizing the Plac1 phenotype. It is an automated high-throughput phenotyping platform 
that allows unobtrusive and low-stress observation and analysis of spontaneous behavior of 
several mice simultaneously. Although it has been recently proven to be a reliable and sensitive 
tool in behavioral analysis (Clemens et al., 2014; Urbach et al., 2014) extensive validation is still 
needed (Tecott & Nestler, 2004; van der Staay & Steckler, 2001). An increase in the number of 
screened mice over a greater range of ages could allow the use of multivariate models, such 
Partial Least Squares Discriminant Analysis, to better describe an overall Plac1-deficient 
phenotype and make greater use of the collected data. 
Results from these studies revealed that HETs exhibited decreased activity and increased 
rearing during the acclimation phase at 5 months, and increased exploration, peripheral 
movement, and rearings throughout the entire experiment at 12 months, compared to female WT 
(WT-F) equivalents. These results suggest potential motor, anxiety, and memory-related 
deficiencies that we qualify by classical behavioral testing. 
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The elevated plus maze (EPM) and open field test (OF) are established tests used to 
assess state anxiety-related behavior in rodents (Hazim, Ramanathan, Parthasarathy, Muzaimi, & 
Mansor, 2014; Uys, Stein, Daniels, & Harvey, 2003). The OF test relies on the conflict between 
the exploration of novel environment and the fear of open spaces. The percentage of time spent 
in the center is the primary assay for anxious behavior (Prut & Belzung, 2003). Likewise, the 
EPM pits aversion to elevated open spaces against the innate tendency to explore. Percentage of 
time and number of entries into the open arms is used to assess anxiety and performance of 
anxiolytics (Lister, 1987; Uys et al., 2003). We show that while HETs perform identically to 
WT-F in the OF test, HETs have reduced head entries into open arms, do not explore the entirety 
of the open arms, exhibit reduced exploratory behavior, and spend more time immobile or 
frozen. Anxious behavior as seen on the EPM has been associated with knockout of serotonin 
transporter 5-HTT and serotonin receptor 1A (Holmes, Lit, Murphy, Gold, & Crawley, 2003; 
Ramboz et al., 1998), and decrease in GABAA neurotransmission (Andolina, Maran, Viscomi, & 
Puglisi-Allegra, 2014; Ishihara, Hiramatsu, Kameyama, & Nabeshima, 1993). This suggests 
Plac1 may have a role in the development of serotinergic or GABAergic circuits. 
The lack of genotype effect of Plac1 on anxiety-related statistics in the OF test may be 
due to several reasons. First, the EPM is usually considered a more sensitive test of anxiety 
(Ramos, 2008). Second, it has been shown that EPM and OF measure different aspects of 
anxious behavior. The measures of stress response between these tests depended on distinct 
factors, and conflicting test results between OF and EPM is encountered often in 
pharmacological screening (Anchan, Clark, Pollard, & Vasudevan, 2014; Ramos, 2008; Ramos, 
Mellerin, Mormede, & Chaouloff, 1998; Vendruscolo, Takahashi, Bruske, & Ramos, 2003). 
Third, the OF test may not encompass all measures of anxiety (Prut & Belzung, 2003). Multiple 
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tests are often encouraged to gain a more comprehensive picture of rodent behavior (Ramos, 
2008; van Gaalen & Steckler, 2000). 
We show that HETs perform equivalently to WT-F on the Rotarod, suggesting 
coordination, balance, and motor learning are largely unaffected in HETs. Cerebellar 
performance, a key determinant of Rotarod results (Lalonde, Bensoula, & Filali, 1995), is 
probably unaffected in HETs. The decrease in locomotor parameters seen in PhenoMaster 
analysis and the EPM are likely related to exploratory or anxious behavior rather than an 
inability to move. Furthermore, satisfactory performance on the radial arm water open maze 
variant confirms that HETs have the ability to see and move properly. It would be interesting to 
test KOs on the Rotarod, as there was observable dysmorphia and neuronal depletion in the 
cerebellum of a Plac1 knockout that might hinder locomotion. 
The Y-maze, novel object recognition (NOR), and radial arm water maze (RAWM) are 
all useful behavioral assays for uncovering deficits in memory, locomotion, and cognition. The 
Y-maze is typically employed as a measure of spatial working memory (Dridi et al., 2014). The 
NOR task is sensitive for cognition and recognition memory deficits (Grayson et al., 2014). The 
RAWM can be used to detect problems with spatial memory and learning (Alamed, Wilcock, 
Diamond, Gordon, & Morgan, 2006; Shukitt-Hale, McEwen, Szprengiel, & Joseph, 2004). WT-
F and HETs performed similarly in all three tests, suggesting that HETs have no significant 
deficits in spatial memory, learning, or cognition. These performances are classically linked to 
hippocampal function (King, Trinkler, Hartley, Vargha-Khadem, & Burgess, 2004), implying 
HET hippocampi are largely normal. However, recent review proposes that certain aspects of 
anxiety are associated with the hippocampus (Bannerman et al., 2014). It is unclear how EPM-
related anxiety results and spatial memory performance correlate. 
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Plac1 Xm-X heterozygotes appear to be spared from aforementioned gross anatomical 
malformations, adulthood neuronal loss, reduced axonal development and migration, and 
microglial activation. Although the paternal allele is largely silenced, the small amount of 
residual expression that escapes inactivation appears to provide some degree of functional 
compensation during development. This is consistent with the observed paternal imprinting of 
Plac1 in maternal-allele Plac1 mutants (Jackman et al., 2012). However, the increased 
susceptibility of HETs to HC, abnormal phenotypes of HET embryo and placenta (Jackman et 
al., 2012), and reported distinct behavioral differences, strongly suggests there may be some 
other manifestation of nervous system insult. Methods used for these studies may not have 
detected subtle structural differences between HETs and WT-F brains. The comparison can be 
expanded in several directions: incorporating more brain cell markers, such as astrocytes or 
oligodendrocytes, using Weil stain to check for myelin, including a wider array of mice brain 
ages, or analyzing certain neuronal circuits. 
As the cellular function, location, and expression regulation of Plac1 expression have not 
been fully characterized, it is impossible to highlight a causative role for Plac1 in the 
development of the nervous system. It is possible the altered neural phenotype of Plac1 HETs 
and KOs may result from aberrations in placental nutrient transport rather than direct action of 
Plac1 in the developing brain. Recently, the placenta has been identified as an exclusive source 
of serotonin for forebrain development between E10.5 and E15.5 of mouse development (Bonnin 
et al., 2011). This is interesting given the association between Plac1 Xm-X heterozygotes and 
possible serotonin-related anxiety. However, the small but detectable presence of Plac1 in the 
embryonic brain suggests a more active role. Additionally, differential microarray analysis of 
E18.5 KO placentae revealed downregulation of several genes important in embryogenesis, 
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including Bmp, Wnt, and Pdgf (Fant, unpublished data). Heavily implicated affected canonical 
systems include “ES Cell Pluripotency”, “Integrin Signaling”, “Glioblastoma Multiform 
Signaling”, and “Axonal Guidance Signaling”, further suggesting a direct role for Plac1 in 
neural development. Selective tissue knockouts for Plac1 can help examine the relative 
importance of expression in these respective organs. Elucidation of PLAC1 function and 
potential protein interactions will shed light into Plac1’s role in neural development. 
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APPENDIX A: 
IACUC APPROVAL DOCUMENTATION 
 
 Procedures and protocols such as timed matings between mice were carried out in 
accordance with Institutional Animal Care and Use Committee (IACUC) of the University of 
South Florida College of Medicine Protocol Number R4228. The following pages are scans of 
IACUC approval documentation for the two years this study was conducted. 
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